TFF Pharmaceuticals, Inc.

NASDAQ:TFFP

0.065 (USD) • At close December 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 0.1930.650.2030.73400.3330.05100000000000000000000
Cost of Revenue 00.1410.140.1310.1250.1240.1230.1210.1010.0890.0770.0770.0280.0040.001000000000000
Gross Profit 0.1930.510.0630.603-0.1250.21-0.072-0.121-0.101-0.089-0.077-0.077-0.028-0.004-0.001000000000000
Gross Profit Ratio 10.7840.310.82200.629-1.39500000000000000000000
Reseach & Development Expenses 1.6952.5883.5562.9742.3872.6824.0194.1364.0265.1115.2626.926.342.7625.2783.0552.8242.5682.2363.2682.5641.321.6710.0890.140.6190
General & Administrative Expenses 2.0812.0242.322.5092.2692.673.1193.5583.3423.693.2463.1882.3882.3512.6472.8642.2551.2751.6181.4440.3010.8890.53200.46600
Selling & Marketing Expenses 00-0.14-0.13100000000000000000000000
SG&A 2.0812.0242.2982.3782.2692.673.1193.5583.3423.693.2463.1882.3882.3512.6472.8642.2551.2751.6181.4440.3010.8890.5320.8060.4661.5080.269
Other Expenses 0000.166-0.077-0.037-0.051-0.313-0.0880.0210.0570.037-0.0130.4420.231000000000000
Operating Expenses 3.7754.6135.8545.3524.4215.0197.0867.3817.2818.7738.4410.0968.6785.1117.9015.9195.0793.8433.8534.7122.8642.2092.2020.8950.6062.1280.269
Operating Income -3.582-3.963-5.994-5.483-4.421-5.019-7.086-7.381-7.281-8.773-8.44-10.096-8.678-5.111-7.901-5.919-5.079-3.843-3.853-4.712-2.864-2.209-2.202-0.895-0.606-2.128-0.269
Operating Income Ratio -18.523-6.094-29.488-7.4710-15.056-137.79100000000000000000000
Total Other Income Expenses Net 0.037-0.5170.0560.6060.011-0.0010.035-0.070.0060.0260.0640.059-0.0010.4560.2470.0240.0210.0260.0560.050.0260.0220.020.0230.0210.0110.002
Income Before Tax -3.545-4.479-5.735-4.762-4.409-5.02-7.051-7.373-7.275-8.746-8.376-10.05-8.679-4.656-7.655-5.895-5.058-3.817-3.797-4.662-2.838-2.187-2.183-0.872-0.585-2.117-0.268
Income Before Tax Ratio -18.331-6.889-28.214-6.4890-15.06-137.10900000000000000000000
Income Tax Expense 00-00-0.089-0.036-0.1580.006-0.006-0.006-0.007-0.01-0.012-0.014-0.017-0.055-0.053-0.051-0.047-0.046-0.045-0.041-0.040000
Net Income -3.545-4.479-5.735-4.762-4.409-5.02-6.893-7.379-7.268-8.746-8.376-10.05-8.679-4.656-7.655-5.895-5.058-3.817-3.797-4.662-2.838-2.187-2.183-0.872-0.585-2.117-0.268
Net Income Ratio -18.331-6.889-28.214-6.4890-15.06-134.03200000000000000000000
EPS -0.81-1.22-2.4-2.01-2.32-3.47-4.76-5.1-0.29-0.34-0.33-0.4-0.34-0.18-0.33-0.26-0.24-0.2-0.2-0.33-0.16-0.12-0.12-1.48-0.033-3.26-0.36
EPS Diluted -0.81-1.22-2.4-2.01-2.32-3.47-4.76-5.1-0.29-0.34-0.33-0.4-0.34-0.18-0.33-0.26-0.24-0.2-0.2-0.33-0.16-0.12-0.12-1.48-0.033-3.26-0.36
EBITDA -3.582-3.963-5.595-5.238-4.284-4.897-6.928-7.252-7.173-8.657-8.299-9.973-8.65-5.111-7.901-5.919-5.079-3.843-3.853-4.662-2.864-2.187-2.202-0.872-0.606-2.117-0.268
EBITDA Ratio -18.523-6.094-28.799-7.2930-14.685-137.79100000000000000000000